| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $426.5M | +65.2% |
| Cost of Revenue | $206.9M | +22.2% |
| Gross Profit | $219.6M | +146.8% |
| R&D Expense | $1.8M | -45.1% |
| SG&A Expense | $74.1M | +25.6% |
| Operating Income | $139.0M | +542.5% |
| Pre-tax Income | $125.7M | +545.2% |
| Income Tax | -$72.0M | — |
| Net Income | $197.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $103.1M | +100.9% |
| Accounts Receivable | $50.0M | +82.3% |
| Inventory | $170.2M | -1.5% |
| Current Assets | $331.4M | +28.9% |
| Total Assets | $488.7M | +48.5% |
| Current Liabilities | $55.5M | +11.5% |
| Total Liabilities | $139.7M | -28.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $118.7M | +1248.5% |
| Capital Expenditures | $8.2M | +72.4% |
| Investing Cash Flow | -$8.6M | -72.2% |
| Financing Cash Flow | -$58.3M | -49.5% |
| Free Cash Flow | $110.4M | +2641.3% |
| +800.0% |
| EPS (Basic) | $0.85 | +753.8% |
| EPS (Diluted) | $0.81 | +723.1% |
| Stockholders' Equity |
| $349.0M |
| +158.1% |